| __timestamp | Amgen Inc. | Amphastar Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4699000000 | 40373000 |
| Thursday, January 1, 2015 | 4846000000 | 46974000 |
| Friday, January 1, 2016 | 5062000000 | 47298000 |
| Sunday, January 1, 2017 | 4870000000 | 50918000 |
| Monday, January 1, 2018 | 5332000000 | 58044000 |
| Tuesday, January 1, 2019 | 5150000000 | 63109000 |
| Wednesday, January 1, 2020 | 5730000000 | 65157000 |
| Friday, January 1, 2021 | 5368000000 | 68920000 |
| Saturday, January 1, 2022 | 5414000000 | 66592000 |
| Sunday, January 1, 2023 | 6179000000 | 80393000 |
| Monday, January 1, 2024 | 7096000000 |
Data in motion
In the competitive world of biopharmaceuticals, understanding operational costs is crucial. Over the past decade, Amgen Inc. and Amphastar Pharmaceuticals, Inc. have shown contrasting trends in their Selling, General, and Administrative (SG&A) expenses. Amgen, a titan in the industry, has consistently reported SG&A expenses that are over 80 times higher than those of Amphastar. From 2014 to 2023, Amgen's expenses grew by approximately 31%, peaking in 2023. In contrast, Amphastar's expenses increased by nearly 99% over the same period, reflecting its growth trajectory. This data highlights the scale and operational strategies of these companies, offering insights into their market positioning and financial health. As the industry evolves, monitoring these expenses can provide a window into future trends and strategic shifts.
Selling, General, and Administrative Costs: Amgen Inc. vs Sanofi
Operational Costs Compared: SG&A Analysis of Amgen Inc. and BioMarin Pharmaceutical Inc.
Comparing SG&A Expenses: Amgen Inc. vs Pharming Group N.V. Trends and Insights
Amgen Inc. vs Apellis Pharmaceuticals, Inc.: SG&A Expense Trends
Amgen Inc. vs Vericel Corporation: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Amgen Inc. or Galapagos NV
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Novavax, Inc.
SG&A Efficiency Analysis: Comparing Regeneron Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Amphastar Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Grifols, S.A. vs Amphastar Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Agios Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Amphastar Pharmaceuticals, Inc. and Evotec SE